Similarly, the concentration of CPA4 in serum was significantly increased in CRC patients, and higher serum CPA4 levels were correlated with poor prognosis and liver metastasis in colorectal cancer patients [37]. This evidence concerns the gene CPA4 and colorectal cancer.